C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 231/14 (2006.01) A61K 31/415 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2703781
4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol- 1 -yl]benzoic acid and pharmaceutically-acceptable salts thereof and a particular crystalline form of the Agent (Form 1); their use in the inhibition of 11 .beta.HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
L'invention concerne un acide 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoïque et sur des sels pharmaceutiquement acceptables de celui-ci ainsi que sur une forme cristalline particulière de l'agent (Forme 1). Elle concerne également leur utilisation dans l'inhibition de 11 ßHSD1, des procédés permettant de les fabriquer et sur des compositions pharmaceutiques les comprenant.
Packer Martin
Scott James Stewart
Stocker Andrew
Whittamore Paul Robert Owen
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoi... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoi..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoi... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1809922